Tumor suppressor p16INK4A: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4

Molecular Cell

Volumn 1, Issue 3, 1998, Pages 421-431

  Byeon, In Ja L ^a   Li, Junan ^a   Ericson, Karen ^a   Selby, Thomas L ^a   Tevelev, Anton ^a   Kim, Hee Jung ^a   O'Maille, Paul ^a   Tsai, Ming Daw ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; ONCOPROTEIN; PROTEIN P16INK4A;

ARTICLE; BINDING SITE; CARCINOGEN TESTING; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; SOLUBILITY;

BINDING SITES; CARCINOGENICITY TESTS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; ESCHERICHIA COLI; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 0031991891     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80042-8     Document Type: Article

References (55)

1. Baghdassarian, N., and Ffrench, M. (1996). Cyclin-dependent kinase inhibitors and hematological malignancies. Hematol. Cell Ther. 38, 313-323.
2. Bax, A., and Davis, D.G. (1985). MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
3. Bork, P. (1993). Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins 17, 363-374.
4. Brünger, A.T. (1992). X-PLOR, Version 3.1: a system for X-ray crystallography and NMR (New Haven and London: Yale University Press).
5. Coleman, K.G., Wautlet, B.S., Morrissey, D., Mulheron, J., Sedman, S.A., Brinkley, P., Price, S., and Webster, K.R. (1997). Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem. 272, 18869-18874.
6. Cordon-Cardo, C. (1995). Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 147, 545-560.
7. De Bondt, H.L., Rosenblatt, J., Jancarik, J., Jones, H.D., Morgan, D.O., and Kim, S.-H. (1993). Crystal structure of cyclin-dependent kinase 2. Nature 363, 595-602.
8. Dyson, N. (1994). pRB, p107 and the regulation of the E2F transcription factor. J. Cell Sci. 18 (Suppl.), 81-87.
9. Fåhraeus, R., Paramio, J.M., Ball, K.L., Lain, S., and Lane, D.P. (1996). Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr. Biol. 6, 84-91.
10. Fesik, A.W., and Zuiderweg, E.R.P. (1988). Heteronuclear 3D NMR spectroscopy. A strategy for the simplification of homonuclear 2D NMR spectra. J. Magn. Reson. 78, 588-593.
11. Fueyo, J., Gomez-Manzano, C., Yung, W.K.A., Clayman, G.L., Liu, T.-J., Bruner, J., Levin, V.A., and Kyritsis, A.P. (1996). Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 12, 103-110.
12. Gorina, S., and Pavletich, N.P. (1996). Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005.
13. Greenwald, I., and Rubin, G.M. (1992). Making a difference: the role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68, 271-281.
14. Hanks, S.K. (1987). Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl. Acad. Sci. USA 84, 388-392.
15. INK4B is a potential effector of TGF-β-induced cell-cycle arrest. Nature 371, 257-261.
16. Helps, N.R., Barker, H.M., Elledge, S.J., and Cohen, P.T. (1995). Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett. 377, 295-300.
17. Hirai, H., Suzuki, T., Fujisawa, J., Inoue, J., and Yoshida, M. (1994). Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91, 3584-3588.
18. INK4 gene mediated by an adenovirus vector. Cancer Res. 55, 3250-3253.
19. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavigian, S., Stockert, E., Day, R., III, Johnson, B., and Skolnick, M. (1994). A cell cycle regulator potentially involved in genesis of many cell types. Science 264, 436-440.
20. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659.
21. Karadi, R., Billeter, M., and Wüthrich, K. (1996). Molmol: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 51-55.
22. Katchalski-Katzir, E., Shariv, I., Eisenstein, M., Friesem, A.A., Aflalo, A., and Vakser, I.A. (1992). Molecular surface recognition: Determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. USA. 89, 2195-2199.
23. Koh, J., Enders, G.H., Dynlacht, B.D., and Harlow, E. (1995). Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
24. Kouzarides, T. (1995). Transcriptional control by the retinoblastoma protein. Semin. Cancer Biol. 6, 91-98.
25. Kuboniwa, H., Grzesiek, S., Delaglio, F., and Bax, A. (1994). Measurement of HN-Ha J couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods. J. Biomol. NMR 4, 871-878.
26. Liu, Q., Neuhausen, S., McClure, M., Frye, C., Weaver-Feldhaus, J., Gruis, N.A., Eddington, K., Ullalunis-Turner, M.J., Skolnick, M.H., Fujimura, F.K., and Kamb, A. (1995). CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10, 1061-1067.
27. INK4D. Nature 389, 999-1003.
28. Lux, S.E., John, K.M., and Bennett, V. (1990). Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344, 36-42.
29. 15N Hartmann-Hahn multiple quantum coherence spectroscopy: application to interleukin 1β. Biochemistry 28, 6150-6156.
30. PSK-J3/cdk4) for mammalian D-type G1 cyclins. Cell 71, 323-334.
31. Meijer, L., and Kim, S.-H. (1997). Chemical inhibitors of cyclin-dependent kinases. Meth. Enzymol. 283, 117-118.
32. INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma. Oncogene 15, 231-235.
33. 13C-edited NOESY experiment. J. Biomol. NMR 3, 463-470.
34. Müller, R. (1995). Transcriptional regulation during the mammalian cell cycle. Trends Genet. 11, 173-178.
35. Nilges, M., Clore, G.M., and Gronenborn, A.M. (1988). Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. FEBS Lett. 239, 129-136.
36. Pace, C.N. (1986). Determination and analysis of urea and guanidine hydrochloride denaturation curves. Meth. Enzymol. 131, 266-280.
37. CDKN2 associated with familial melanoma. Mol. Cell. Biol. 16, 3844-3852.
38. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382, 325-331.
39. 1H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J. Biomol. NMR 5, 97-102.
40. Serrano, M., Gómez-Lahoz, E., DePinho, R.A., Beach, D., and BarSagi, D. (1995). Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267, 249-252.
41. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366, 704-707.
42. Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
43. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res. 55, 6200-6209.
44. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
45. 15N HSQC experiments optimized to retain full sensitivity. J. Magn. Reson. A 102, 241-245.
46. INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15, 1607-1614.
47. Suzuki-Takahashi, I., Kitagawa, M., Saijo, M., Higashi, H., Ogino, H., Matsumoto, H., Taya, Y., Nishimura, S., and Okuyama, A. (1995). The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 10, 1691-1698.
48. INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35, 9475-9487.
49. Vakser, I.A., and Aflalo, C. (1994). Hydrophobic docking: a proposed enhancement to molecular recognition techniques. Prot. Struct. Funct. Genet. 20, 320-329.
50. 13C-separated HMQC-NOESY-HMQC spectra using pulsed field gradients. J. Magn. Reson. B 101, 210-213.
51. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
52. Whyte, P. (1995). The retinoblastoma protein and its relatives. Semin. Cancer Biol. 6, 83-90.
53. Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Buschenfelde, K.-H., and Beach, D. (1995). A p16(INK4a)-insensitive CDK4 mutant targeted by cytolytic lymphocytes in a human melanoma. Science 269, 1281-1284.
54. INK4D, in tumor-derived cell lines and primary tumors. Oncogene 13, 2033-2038.
55. Zindy, F., Soares, H., Herzog, K.-H., Morgan, J., Sherr, C.J., and Roussel, M.F. (1997). Expression of INK4 inhibitors of cyclin-D kinases during mouse brain development. Cell Growth Differ. 8, 1139-1150.